Silence Therapeutics PLC Replacement - Holding(s) in Company (3319O)
August 17 2017 - 10:05AM
UK Regulatory
TIDMSLN
RNS Number : 3319O
Silence Therapeutics PLC
17 August 2017
Replacement related to RNS #31770 - title changed, all other
details remain the same.
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the
relevant issuer and to the FCA in Microsoft Word format
if possible)(i)
----------------------------------------------------------------------------------------------------
1a. Identity of the issuer Silence Therapeutics Plc
or the underlying issuer
of existing shares to which
voting rights are attached(ii)
:
------------------------------------------------ --------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
----------------------------------------------------------------------------------------------------
Non-UK issuer
------------------------------------------------------------------------------------- -------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------------------- -------------
An acquisition or disposal of financial instruments
------------------------------------------------------------------------------------- -------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------- -------------
Other (please specify)(iii) :
------------------------------------------------------------------------------------- -------------
3. Details of person subject to the notification obligation(iv)
Name Richard Griffiths and controlled
undertakings
City and country of registered St Helier, Jersey, Channel
office (if applicable) Islands
4. Full name of shareholder(s) (if different from
3.)(v)
----------------------------------------------------------------------------------------------------
Name
------------------------------------------------ --------------------------------------------------
City and country of registered
office (if applicable)
------------------------------------------------ --------------------------------------------------
5. Date on which the threshold 15 August 2017
was crossed or reached(vi)
:
------------------------------------------------ --------------------------------------------------
6. Date on which issuer 17 August 2017
notified (DD/MM/YYYY):
------------------------------------------------ --------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
----------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
----------------------- ----------------------- ---------------- ----------------- -------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 27.30% 0.00% 27.30% 69,991,624
----------------------- ----------------------- ---------------- ----------------- -------------
Position
of previous
notification
(if
applicable) 26.92% 0.00% 26.92%
----------------------- ----------------------- ---------------- ----------------- -------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
------------------------------------------------------------------------------------------------------
Class/type of Number of voting rights(ix) % of voting rights
shares
ISIN code (if
possible)
-------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10
Directive Directive Directive of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
----------------- ---------------- -------------- ----------------------------- ----------------
GB00B9GTXM62 19,104,633 0 27.30% 0.00%
------------------- ---------------- -------------- ----------------------------- ----------------
SUBTOTAL 8. A 19,104,633 27.30%
------------------- -------------------------------- -----------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
------------------- ---------------- -------------- ----------------------------- ----------------
SUBTOTAL 8.
B 1
-------------- ----------------------------- ----------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1
(b))
------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Physical Number % of voting
instrument date(x) Conversion or cash of voting rights
Period settlement(xii) rights
(xi)
------------------ ----------------- -------------- ---------------- ----------- ----------------
SUBTOTAL
8.B.2
---------------- ----------- ----------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which X
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
----------------------------------------------------------------------------------- --------------
Name(xv) % of voting % of voting Total of
rights if rights through both if
it equals financial it equals
or is higher instruments or is higher
than the notifiable if it equals than the
threshold or is higher notifiable
than the threshold
notifiable
threshold
------------------ -------------------------------- ---------------- ---------------------------
Blake Holdings
Limited 11.07% 0.00% 11.07%
------------------ -------------------------------- ---------------- ---------------------------
Seren Investment
Management
Limited 11.85% 0.00% 11.85%
------------------ -------------------------------- ---------------- ---------------------------
Sarossa Plc 3.13% 0.00% 3.13%
------------------ -------------------------------- ---------------- ---------------------------
Oak Trust Limited 0.26% 0.00% 0.26%
------------------ -------------------------------- ---------------- ---------------------------
Richard Griffiths
and family 0.99% 0.00% 0.99%
------------------ -------------------------------- ---------------- ---------------------------
Total 27.30% 0.00% 27.30%
------------------ -------------------------------- ---------------- ---------------------------
10. In case of proxy voting, please identify:
---------------------------------------------------------------------------------------------------
Name of the proxy holder N/A
---------------------------------------------------- ---------------------------------------------
The number and % of voting N/A
rights held
---------------------------------------------------- ---------------------------------------------
The date until which the voting N/A
rights will be held
---------------------------------------------------- ---------------------------------------------
11. Additional information(xvi)
---------------------------------------------------------------------------------------------------
Place of St Helier, Jersey, Channel Islands
completion
------------------- -----------------------------------
Date of completion 17 August 2017
------------------- -----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEDLFFDVFBBBF
(END) Dow Jones Newswires
August 17, 2017 11:05 ET (15:05 GMT)
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Apr 2024 to May 2024
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Silence Therapeutics Plc (London Stock Exchange): 0 recent articles
More Silence Ther. News Articles